Cargando…
Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs
BACKGROUND: Antibodies have been a pillar of basic research, while their relevance in clinical diagnostics and therapy is constantly growing. Consequently, the production of both conventional and fragment antibodies constantly faces more demanding challenges for the improvement of their quantity and...
Autor principal: | de Marco, Ario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557595/ https://www.ncbi.nlm.nih.gov/pubmed/26330219 http://dx.doi.org/10.1186/s12934-015-0320-7 |
Ejemplares similares
-
Poly(Beta-Amino Ester)s as High-Yield Transfection Reagents for Recombinant Protein Production
por: Luly, Kathryn M, et al.
Publicado: (2022) -
Recombinant polypeptide production in E. coli: towards a rational approach to improve the yields of functional proteins
por: de Marco, Ario
Publicado: (2013) -
Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies
por: Djender, Selma, et al.
Publicado: (2014) -
Biotechnological applications of recombinant single-domain antibody fragments
por: de Marco, Ario
Publicado: (2011) -
CDR1 Composition Can Affect Nanobody Recombinant Expression Yields
por: Orlando, Marco, et al.
Publicado: (2021)